Voyager Therapeutics (VYGR) Operating Margin (2016 - 2025)
Historic Operating Margin for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to 228.31%.
- Voyager Therapeutics' Operating Margin fell 1723600.0% to 228.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 446.84%, marking a year-over-year decrease of 4523900.0%. This contributed to the annual value of 104.11% for FY2024, which is 1529100.0% down from last year.
- Per Voyager Therapeutics' latest filing, its Operating Margin stood at 228.31% for Q3 2025, which was down 1723600.0% from 704.33% recorded in Q2 2025.
- Voyager Therapeutics' Operating Margin's 5-year high stood at 1584.71% during Q4 2022, with a 5-year trough of 3244.68% in Q1 2022.
- Over the past 5 years, Voyager Therapeutics' median Operating Margin value was 393.62% (recorded in 2021), while the average stood at 621.28%.
- Per our database at Business Quant, Voyager Therapeutics' Operating Margin plummeted by -28510600bps in 2022 and then surged by 33263400bps in 2023.
- Voyager Therapeutics' Operating Margin (Quarter) stood at 20.31% in 2021, then soared by 7702bps to 1584.71% in 2022, then plummeted by -96bps to 60.03% in 2023, then tumbled by -1116bps to 610.05% in 2024, then surged by 63bps to 228.31% in 2025.
- Its last three reported values are 228.31% in Q3 2025, 704.33% for Q2 2025, and 533.74% during Q1 2025.